DD233076A5 - Verfahren zur herstellung eines pharmazeutischen praeparates zur therapeutischen behandlung von rheumatischen erkrankung - Google Patents

Verfahren zur herstellung eines pharmazeutischen praeparates zur therapeutischen behandlung von rheumatischen erkrankung Download PDF

Info

Publication number
DD233076A5
DD233076A5 DD84271295A DD27129584A DD233076A5 DD 233076 A5 DD233076 A5 DD 233076A5 DD 84271295 A DD84271295 A DD 84271295A DD 27129584 A DD27129584 A DD 27129584A DD 233076 A5 DD233076 A5 DD 233076A5
Authority
DD
German Democratic Republic
Prior art keywords
diacyl
glycero
phosphocholine
item
oxicam
Prior art date
Application number
DD84271295A
Other languages
German (de)
English (en)
Inventor
Armin Wendel
Helmut Wetzig
Manfred Duerr
Sigurd Leyck
Joerg Hager
Miklos Ghyczy
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of DD233076A5 publication Critical patent/DD233076A5/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
DD84271295A 1983-12-22 1984-12-20 Verfahren zur herstellung eines pharmazeutischen praeparates zur therapeutischen behandlung von rheumatischen erkrankung DD233076A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3346526A DE3346526C2 (de) 1983-12-22 1983-12-22 Pharmazeutisches Präparat zur therapeutischen Behandlung von rheumatischen Erkrankungen

Publications (1)

Publication Number Publication Date
DD233076A5 true DD233076A5 (de) 1986-02-19

Family

ID=6217768

Family Applications (1)

Application Number Title Priority Date Filing Date
DD84271295A DD233076A5 (de) 1983-12-22 1984-12-20 Verfahren zur herstellung eines pharmazeutischen praeparates zur therapeutischen behandlung von rheumatischen erkrankung

Country Status (24)

Country Link
US (1) US4687766A (ko)
EP (1) EP0147735B1 (ko)
JP (1) JPS60169420A (ko)
KR (1) KR920003602B1 (ko)
AT (1) ATE40793T1 (ko)
AU (1) AU566974B2 (ko)
CA (1) CA1234049A (ko)
DD (1) DD233076A5 (ko)
DE (2) DE3346526C2 (ko)
DK (1) DK619484A (ko)
EG (1) EG17137A (ko)
ES (1) ES8707111A1 (ko)
FI (1) FI83287C (ko)
GR (1) GR82545B (ko)
HU (1) HU193729B (ko)
IL (1) IL73849A (ko)
IN (1) IN162327B (ko)
MX (1) MX159874A (ko)
NO (1) NO166569C (ko)
NZ (1) NZ210648A (ko)
OA (1) OA07907A (ko)
PH (1) PH21823A (ko)
PT (1) PT79649B (ko)
ZA (1) ZA849976B (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5154930A (en) * 1987-03-05 1992-10-13 The Liposome Company, Inc. Pharmacological agent-lipid solution preparation
US5376381A (en) * 1988-02-25 1994-12-27 The Liposome Company, Inc. Integrity protected gelatin
GB9212450D0 (en) * 1992-06-11 1992-07-22 Indena Spa New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5763422A (en) * 1995-01-27 1998-06-09 Board Of Regents, The University Of Texas System Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
US5955451A (en) * 1995-05-12 1999-09-21 The University Of Texas System Board Of Regents Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
AUPN766496A0 (en) * 1996-01-22 1996-02-15 University Of New England, The Method and composition for the potentiation of anti-inflammatory drugs
PL371626A1 (en) * 2002-01-21 2005-06-27 Vasogen Ireland Limited Pharmaceutically acceptable phosphate-glycerol carrying bodies
BR0215680A (pt) * 2002-04-26 2005-02-01 Rudolf Perl Composição farmacêutica oral estável
EP1658086A2 (en) * 2003-07-21 2006-05-24 Vasogen Ireland Limited Liposomes containing phosphate glycerol groups for treating acute inflammatory condition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3787324A (en) * 1971-03-01 1974-01-22 Warner Lambert Co 4-hydroxy-3-(3-isoxazolocarbamyl)-2h-1,2-benzothiazine 1,dioxides and process for their production
FR2343481A1 (fr) * 1976-03-11 1977-10-07 Gerlich Norbert Composition destinee a empecher les lesions des membranes biologiques et a regenerer ces membranes une fois qu'elles ont ete endommagees
AU518216B2 (en) * 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
JPS54117034A (en) * 1978-02-28 1979-09-11 Nippon Shoji Kk Treating agent for consciousness and perception motion disorder
DE2856333C2 (de) * 1978-12-27 1983-09-22 A. Nattermann & Cie GmbH, 5000 Köln Oral einnehmbare Arzneimittel mit entzündungshemmender Wirkung
DE2856339C2 (de) * 1978-12-27 1985-12-05 Fortuna-Werke Maschinenfabrik Gmbh, 7000 Stuttgart Vorrichtung zum kontinuierlichen, automatischen Zustellen von Setzstockbacken zur Halterung eines Werkstückes auf einer Rundschleifmaschine
DE2914788A1 (de) * 1979-04-11 1980-10-16 Nattermann A & Cie Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
DE3047012A1 (de) * 1980-12-13 1982-07-22 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zur abtrennung von acylierten phospholipiden aus diese enthaltenden phosphatidylcholin-produkten
DE3047048A1 (de) * 1980-12-13 1982-07-29 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zur abtrennung von oel und/oder phosphatidylethanolamin aus diese enthaltenden alkoholloeslichen phosphatidylcholin-produkten
DE3047011A1 (de) * 1980-12-13 1982-07-22 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zur abtrennung von oel und/oder phosphatidylethanolamin aus diese enthaltenden alkoholloeslichen phosphatidylcholin-produkten
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
US4434163A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Water-soluble benzothiazine dioxide salts
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten

Also Published As

Publication number Publication date
EP0147735A2 (de) 1985-07-10
US4687766A (en) 1987-08-18
JPS60169420A (ja) 1985-09-02
FI845019L (fi) 1985-06-23
EP0147735A3 (en) 1985-11-27
IL73849A0 (en) 1985-03-31
ES8707111A1 (es) 1987-07-16
FI845019A0 (fi) 1984-12-19
FI83287B (fi) 1991-03-15
DE3346526A1 (de) 1985-07-04
DE3476734D1 (en) 1989-03-23
AU3668584A (en) 1985-06-27
NZ210648A (en) 1988-04-29
EP0147735B1 (de) 1989-02-15
PH21823A (en) 1988-03-04
FI83287C (fi) 1991-06-25
DK619484D0 (da) 1984-12-21
HU193729B (en) 1987-11-30
ZA849976B (en) 1985-08-28
KR850004395A (ko) 1985-07-15
DK619484A (da) 1985-06-23
IN162327B (ko) 1988-04-30
NO166569C (no) 1991-08-14
HUT35958A (en) 1985-08-28
EG17137A (en) 1992-12-30
ATE40793T1 (de) 1989-03-15
MX159874A (es) 1989-09-25
NO844889L (no) 1985-06-24
IL73849A (en) 1988-07-31
CA1234049A (en) 1988-03-15
PT79649B (en) 1986-10-21
DE3346526C2 (de) 1986-12-11
AU566974B2 (en) 1987-11-05
OA07907A (en) 1986-11-20
NO166569B (no) 1991-05-06
KR920003602B1 (ko) 1992-05-04
ES538982A0 (es) 1987-07-16
PT79649A (en) 1985-06-03
GR82545B (en) 1985-04-24
JPH0112729B2 (ko) 1989-03-02

Similar Documents

Publication Publication Date Title
DE2624025C2 (ko)
EP0147741B1 (de) Pharmazeutische Zubereitung mit speziellen 1,2-Diacyl-Glycero-3-Phosphocholinen zur Behandlung von Erkrankungen im Magen-Darmbereich
DE3641491A1 (de) Arzneimittel mit antitumorwirkung
EP0998932A1 (de) Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
DE3027073A1 (de) 2-phenyl-1,2-benzisoselenazol-3(2h)-on enthaltende pharmazeutische praeparate und ihre verwendung
EP1509207B1 (de) Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung
DE3346526C2 (de) Pharmazeutisches Präparat zur therapeutischen Behandlung von rheumatischen Erkrankungen
DE3613799C1 (de) Verwendung von Glycofurol zum Verfluessigen von Arzneimittelzubereitungen fuer das Abfuellen in Weichgelatinekapseln
DE3511609C2 (ko)
DE10029770A1 (de) Verwendung von Curcuminen zur Behandlung von soliden Tumoren,insbesondere von Hirntumoren
DE69907509T2 (de) Pphospholipidkomplexe von proanthocyanidin a2 als antiatherosklerotische mittel
WO1996019212A1 (de) Verwendung von boswelliasäure zur behandlung von hirntumoren
DE4401554A1 (de) Präparat zur Therapie und Prophylaxe von Erkrankungen, die bei Imbalancen von Plasmalipiden auftreten
EP0461290A1 (de) Flüssig befüllte Steckkapselpräparate
EP0263493A2 (de) Pharmazeutische Präparate zur verbesserten gastrointestinalen Resorption
CH667592A5 (de) 9,10-dihydrogenierte ergotalkaloide enthaltende pharmazeutische zusammensetzungen.
DE2448119A1 (de) Pharmazeutische zubereitungen
DD209735A5 (de) Verfahren zur herstellung eines neuen arzneimittelpraeparates
DE1617418C3 (de) Herstellung von festen Arzneimittelformen mit verzögerter Wirkstoffabgabe
AT388101B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur oralen verabreichung mit kontrollierter wirkstofffreisetzung
DE3419130A1 (de) Nifedipinkombinationspraeparate und verfahren zu ihrer herstellung
DE2456172C3 (de) Arzneimittel bei rheumatischen Erkrankungen
DE3810350A1 (de) Dhp-retard-zubereitung
DE2456172B2 (de) Arzneimittel bei rheumatischen erkrankungen
DE3007251A1 (de) Oral applizierbare arzneiform

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee